AIDS Drug Safety, Clinical Trial Administration Defended By NIAID Chief
This article was originally published in The Pink Sheet Daily
Executive Summary
National Institute of Allergy & Infectious Diseases Director Fauci says the safety and efficacy of Boehringer Ingelheim’s nevirapine has been affirmed by numerous studies and that reports to the contrary are damaging to treatment efforts in sub-Saharan Africa.